1. Development and validation of a high-throughput LC–MS/MS assay for routine measurement of molecular ceramides
- Author
-
Marko Sysi-Aho, Kaisa M. Koistinen, Kim Ekroos, Dimple Kauhanen, Reijo Laaksonen, Juha Sinisalo, Clinicum, Kardiologian yksikkö, and Department of Medicine
- Subjects
0301 basic medicine ,Ceramide ,Accuracy and precision ,Analyte ,ELECTROSPRAY-IONIZATION ,SAMPLES ,030204 cardiovascular system & hematology ,Ceramides ,Cardiovascular ,Mass spectrometry ,METABOLITES ,Biochemistry ,Analytical Chemistry ,LIPID ANALYSIS ,Clinical ,SPHINGOLIPIDOMICS ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Simple sample ,Tandem Mass Spectrometry ,Lc ms ms ,High throughput ,Humans ,TANDEM MASS-SPECTROMETRY ,Routine analysis ,Chromatography ,PLASMA ,EXTRACTS ,Chemistry ,QUANTITATIVE-ANALYSIS ,PERFORMANCE LIQUID-CHROMATOGRAPHY ,High-Throughput Screening Assays ,030104 developmental biology ,Human plasma ,3121 General medicine, internal medicine and other clinical medicine ,Calibration ,1182 Biochemistry, cell and molecular biology ,lipids (amino acids, peptides, and proteins) ,Chromatography, Liquid - Abstract
Monitoring the levels of the ceramides (Cer) d18:1/16:0, Cer d18:1/18:0, Cer d18:1/24:0, and Cer d18:1/24:1 and ratios thereof in human plasma empowers the prediction of fatal outcome of coronary artery disease (CAD). We describe a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodology for clinical-scaled measurement of the four distinct ceramides. Rapid plasma precipitation was accomplished in 96-well format. Excellent extraction recoveries in the range of 98-109 % were achieved for each ceramide. Addition of corresponding D-7-labeled ceramide standards facilitated precise quantification of each plasma ceramide species utilizing a novel short 5-min LC-MS/MS method. Neither matrix interference nor carryover was observed. Robust intra- and inter-assay accuracy and precision 0.99, were achieved for all analytes. Short-term bench top, long-term plasma, and extract stability demonstrated that the distinct ceramides were stable in the conditions evaluated. The validity of the methodology was demonstrated by determining the precise ceramide concentrations in a small CAD case-control study. Thus, our LC-MS/MS methodology features simple sample preparation and short analysis time for accurate quantification of Cer d18:1/16:0, Cer d18:1/18:0, Cer d18:1/24:0, and Cer d18:1/24:1, designed for routine analysis.
- Published
- 2016
- Full Text
- View/download PDF